Drug intelligence / Profile preview

myo-inositol + alpha-lipoic acid + folic acid

Development stage
Unknown
Lead developer
Laborest
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

A combination of myo-inositol, alpha-lipoic acid, and folic acid is a nutraceutical supplement primarily used to support reproductive health and metabolic function. Myo-inositol acts as an insulin sensitizer and supports cellular signaling pathways involved in glucose metabolism and ovarian function. Alpha-lipoic acid is a potent antioxidant that also improves insulin sensitivity, reduces oxidative stress, and has anti-inflammatory properties. Folic acid (vitamin B9) is essential for DNA synthesis, red blood cell formation, homocysteine metabolism, and fetal neural development during pregnancy. This combination has been studied for its potential benefits in improving oocyte quality and embryo development in women undergoing IVF (in vitro fertilization), particularly those who are overweight or obese but do not have PCOS[2]. It is also investigated for improving sperm parameters in sub-fertile men[1], as well as for managing symptoms of polycystic ovary syndrome (PCOS), including menstrual irregularities, hyperandrogenism, insulin resistance, and metabolic disturbances[4][9]. The synergistic effect of myo-inositol with alpha-lipoic acid appears to enhance insulin sensitivity more than either agent alone[4][9]. The product Sinopol (Laborest) is one example of this specific combination available commercially.

Brand names
Sinopol
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on myo-inositol + alpha-lipoic acid + folic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on myo-inositol + alpha-lipoic acid + folic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call